Pacritinib
Idiopathic Pulmonary Fibrosis
Clinical trials
1
Developer
National Cancer Institute (NCI)
Overview
Pacritinib is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 1 tracked IPF clinical trial.
Pacritinib clinical trials
Explore related
Medical disclaimer. This page summarizes research about Pacritinib for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.